Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
3.830
-0.290 (-7.04%)
Nov 7, 2025, 12:23 PM EST - Market open
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $40.36 million as of November 7, 2025. Its market cap has decreased by -42.77% in one year.
Market Cap
40.36M
Enterprise Value
37.74M
1-Year Change
-42.77%
Ranking
Category
Stock Price
$3.83
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $40.36M, a decrease of -67.75%. That is a compound annual growth rate of -50.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 43.42M | -7.73% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 813.17B |
| Johnson & Johnson | 449.96B |
| AbbVie | 385.78B |
| UnitedHealth Group | 287.27B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 218.58B |
| Thermo Fisher Scientific | 215.64B |